| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8708968 | Sleep Medicine | 2018 | 7 Pages |
Abstract
Changes in sleep quality, and baseline and changes in SIT discomfort were prominent predictors of treatment response for GEn and placebo. Predictors of treatment response may allow for more targeted enrollment in future clinical trials and may provide insights into the efficacy of RLS treatments.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
John W. Winkelman, Mark J. Jaros,